{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Nonhormonal Treatment of Vasomotor Symptoms - Vol. 37, No. 3

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Educate patients on the potential advantages and disadvantages of initiating nonhormonal therapy for vasomotor symptoms (VMS).
  2. Compare the effectiveness and the potential adverse effects of various classes of pharmaceuticals for the treatment of VMS.
  3. Apply current evidence to recommend effective nonhormonal, nonpharmaceutical options for treatment of VMS in uncomplicated postmenopausal women.
Price: $49.00

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PGO0217
Published: February 28, 2017
Expires: 1/1/2026
Required Passing Score: 7/10 (70%)
Authors: Kathryn P. Gard, MD, Kathryn I. Marko, MD, and Nancy D. Gaba, MD
Categories: Obstetrical , Women's Health
Specialties: OB/GYN